RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
"blood clots after receiving the Oxford-AstraZeneca covid-19 #vaccine have concluded that these are a “possible” and “extremely rare” side effect" @bmj_latest https://t.co/PDsP849s3P
RT @BrendaCrabtreeR: 1 en 250 mil vacunados por #AstraZeneca puede desarrollar eventos trombóticos, lo cual es extremadamente raro. No se t…
@giangoSGV "Se la lUE sui vaccini si dimostra inefficace, pronti ad agire da soli". Così parlò🐲🐲. Salvo poi agire come agiscono i tedeschi, mentre in UK suggeriscono l'opzionalità nella scelta dei vaccini a chi di fatto è a bassissimo rischio. È tutto bell
RT @BrendaCrabtreeR: 1 en 250 mil vacunados por #AstraZeneca puede desarrollar eventos trombóticos, lo cual es extremadamente raro. No se t…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
RT @BrendaCrabtreeR: 1 en 250 mil vacunados por #AstraZeneca puede desarrollar eventos trombóticos, lo cual es extremadamente raro. No se t…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
RT @BrendaCrabtreeR: 1 en 250 mil vacunados por #AstraZeneca puede desarrollar eventos trombóticos, lo cual es extremadamente raro. No se t…
RT @BrendaCrabtreeR: 1 en 250 mil vacunados por #AstraZeneca puede desarrollar eventos trombóticos, lo cual es extremadamente raro. No se t…
RT @BrendaCrabtreeR: 1 en 250 mil vacunados por #AstraZeneca puede desarrollar eventos trombóticos, lo cual es extremadamente raro. No se t…
RT @BrendaCrabtreeR: 1 en 250 mil vacunados por #AstraZeneca puede desarrollar eventos trombóticos, lo cual es extremadamente raro. No se t…
1 en 250 mil vacunados por #AstraZeneca puede desarrollar eventos trombóticos, lo cual es extremadamente raro. No se tiene que dar tromboprofilaxis ni nada. El beneficio de la vacuna es por mucho mayor a dicho riesgo. https://t.co/BxG9RVphvp
@DrPacoMoreno1 La liga está acá: https://t.co/PvgwN14nCR
If it’s only “possible” and “extremely rare” why bother announcing a change to Moderna and Pfizer? Don’t be silly. Oh and btw if you think they will start giving 18-30yr olds the latter 2, you missed the key words in yesterday’s briefing : “where available
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @emahase_: Investigations by EU and UK regulators into reports of unusual blood clots following the Oxford-AstraZeneca vaccine have conc…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
RT @emahase_: Investigations by EU and UK regulators into reports of unusual blood clots following the Oxford-AstraZeneca vaccine have conc…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
RT @giordanopg: Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se de…
Se sigue investigando si la vacuna de AstraZeneca se asocia a trombosis. Aún si se comprueba, el riesgo es muy bajo y se debe poner en contexto. https://t.co/Xt14lx428c https://t.co/nSWo2I5k0i
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @emahase_: Meanwhile, UK gov's advisory committee said low risk under 30s will be offered an alternative vaccine This is based on a ris…
RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
AstraZeneca vaccine: Blood clots are “extremely rare” and benefits outweigh risks, regulators conclude | The BMJ https://t.co/cLqerTmzXP
RT @Fiatopichan: เทียบเห็นภาพ https://t.co/K8P0AMaZqY https://t.co/cPxqJCKi4y
RT @emahase_: Meanwhile, UK gov's advisory committee said low risk under 30s will be offered an alternative vaccine This is based on a ris…
RT @emahase_: Meanwhile, UK gov's advisory committee said low risk under 30s will be offered an alternative vaccine This is based on a ris…
1/2 on unnecessary #AZ panic: "Neither agency established a causal relation". I know I'm rusty on my epi but surely this is a pretty important point, again highlighting there's no need for all the unnecessary panic.
AstraZeneca vaccine: Blood clots are “extremely rare” and benefits outweigh risks, regulators conclude https://t.co/3Kzant7NqJ
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @Fiatopichan: เทียบเห็นภาพ https://t.co/K8P0AMaZqY https://t.co/cPxqJCKi4y
RT @emahase_: Investigations by EU and UK regulators into reports of unusual blood clots following the Oxford-AstraZeneca vaccine have conc…
RT @emahase_: Investigations by EU and UK regulators into reports of unusual blood clots following the Oxford-AstraZeneca vaccine have conc…
RT @emahase_: Investigations by EU and UK regulators into reports of unusual blood clots following the Oxford-AstraZeneca vaccine have conc…
RT @emahase_: Meanwhile, UK gov's advisory committee said low risk under 30s will be offered an alternative vaccine This is based on a ris…
เทียบเห็นภาพ https://t.co/K8P0AMaZqY https://t.co/cPxqJCKi4y
RT @emahase_: Investigations by EU and UK regulators into reports of unusual blood clots following the Oxford-AstraZeneca vaccine have conc…
RT @emahase_: Meanwhile, UK gov's advisory committee said low risk under 30s will be offered an alternative vaccine This is based on a ris…
RT @emahase_: Investigations by EU and UK regulators into reports of unusual blood clots following the Oxford-AstraZeneca vaccine have conc…
RT @emahase_: Meanwhile, UK gov's advisory committee said low risk under 30s will be offered an alternative vaccine This is based on a ris…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @emahase_: Meanwhile, UK gov's advisory committee said low risk under 30s will be offered an alternative vaccine This is based on a ris…
RT @emahase_: Investigations by EU and UK regulators into reports of unusual blood clots following the Oxford-AstraZeneca vaccine have conc…
Meanwhile, UK gov's advisory committee said low risk under 30s will be offered an alternative vaccine This is based on a risk-benefit calculation of ICU admissions vs potential clots & did not consider other benefits e.g. avoiding long covid @bmj_lat
Investigations by EU and UK regulators into reports of unusual blood clots following the Oxford-AstraZeneca vaccine have concluded that these are a “possible” but “extremely rare” side effect. Neither agency established a causal relation. @bmj_latest h
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
AstraZeneca vaccine: Blood clots are “extremely rare” and benefits outweigh risks, regulators conclude https://t.co/Ij3hvdX9Cw
RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
20 million people vaccinated with the AstraZeneca vaccine in the UK , 79 cases of rare blood clots with low platelets have been reported, as well as 19 deaths.
RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
RT @IntraMednet: Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/20…
Poniendo el riesgo en contexto: 1/250.000 personas vacunadas con AstraZeneca desarrollará coágulos con plaquetopenia. 1/2000 mujeres x año desarrollará un coágulos al tomar la píldora anticonceptiva oral. 1/1000 personas x año desarrollará un coágulo debid
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…
RT @bmj_latest: Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19…